☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Glioblastoma
Mustang Bio to Initiate P-I Clinical Trial for MB-101 + MB-108 for the Treatment of Glioblastoma
April 13, 2022
Gan & Lee Receives the US FDA's Fast Track Designation for GLR2007 for the Treatment of Patients with Glioblastoma
February 1, 2021
PharmaShots Interview: Novocure's William F. Doyle Shares Insight on Company's Accomplishments in the Treatment of Glioblastoma an...
December 9, 2020
Novocure and ZaiLab's Optune Receive NMPA's Approval for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
May 14, 2020
AbbVie Reports Results of Depatux-M (depatuxizumab mafodotin) in P-III INTELLANCE-1 Study for Glioblastoma
May 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.